Patents by Inventor Thomas F. Schulz

Thomas F. Schulz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9952203
    Abstract: The present invention relates to a new binder molecule useful e.g. as an immune suppressor. In particular, it has been recognized that the UL11 protein of human the cytomegalovirus, binds to the CD45 molecule, potentially altering the immune system of an individual. In addition, the present invention relates to binder molecules, in particular, fusion molecules containing the CD45 binding domain of the UL11 protein in combination with a second molecule of interest for delivery of said molecule to cells expressing the CD45 molecule. Moreover, the present invention relates to pharmaceutical compositions comprising the UL11 protein of human cytomegalovirus, or derivatives or homologs thereof, or a nucleic acid sequence encoding the same.
    Type: Grant
    Filed: March 21, 2012
    Date of Patent: April 24, 2018
    Assignee: Medizinische Hochschule Hannover
    Inventors: Penelope Kay-Fedorov, Martin Messerle, Thomas F. Schulz, Lars Steinbrück, Ildar Gabaev
  • Publication number: 20140079725
    Abstract: The present invention relates to a new binder molecule useful e.g. as an immune suppressor. In particular, it has been recognized that the UL11 protein of human the cytomegalovirus, binds to the CD45 molecule, potentially altering the immune system of an individual. In addition, the present invention relates to binder molecules, in particular, fusion molecules containing the CD45 binding domain of the UL11 protein in combination with a second molecule of interest for delivery of said molecule to cells expressing the CD45 molecule. Moreover, the present invention relates to pharmaceutical compositions comprising the UL11 protein of human cytomegalovirus, or derivatives or homologs thereof, or a nucleic acid sequence encoding the same.
    Type: Application
    Filed: March 21, 2012
    Publication date: March 20, 2014
    Applicant: MEDIZINISCHE HOCHSCHULE HANNOVER
    Inventors: Penelope Kay-Fedorov, Martin Messerle, Thomas F. Schulz, Lars Steinbrück, Ildar Gabaev